New York State Common Retirement Fund
ZVRA icon

New York State Common Retirement Fund’s Zevra Therapeutics ZVRA Stock Holding History

New York State Common Retirement Fund’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07M Buy
74,742
+36,393
+95% +$405K ﹤0.01% 1723
2026
Q1 		$357K Buy
38,349
+28,242
+279% +$255K ﹤0.01% 2032
2025
Q4 		$90.6K Hold
10,107
– – ﹤0.01% 2654
2025
Q3 		$96.1K Hold
10,107
– – ﹤0.01% 2640
2025
Q2 		$89K Hold
10,107
– – ﹤0.01% 2753
2025
Q1 		$75.7K Hold
10,107
– – ﹤0.01% 2639
2024
Q4 		$84.3K Hold
10,107
– – ﹤0.01% 2663
2024
Q3 		$70.1K Buy
10,107
+7,800
+338% +$52.9K ﹤0.01% 2752
2024
Q2 		$11.3K Buy
2,307
+16
+0.7% +$76 ﹤0.01% 3237
2024
Q1 		$13.3K Sell
2,291
-14,700
-87% -$90.4K ﹤0.01% 3175
2023
Q4 		$111K Sell
16,991
-77
-0.5% -$360 ﹤0.01% 2710
2023
Q3 		$82.3K Buy
17,068
+368
+2% +$1.84K ﹤0.01% 2816
2023
Q2 		$85.2K Buy
+16,700
New +$90K ﹤0.01% 2976
2022
Q3 		– Sell
-181
Closed -$1K – 3470
2022
Q2 		$1K Sell
181
-13,171
-99% -$60K ﹤0.01% 3424
2022
Q1 		$67K Hold
13,352
– – ﹤0.01% 3107
2021
Q4 		$116K Sell
13,352
-50
-0.4% -$446 ﹤0.01% 3038
2021
Q3 		$125K Sell
13,402
-11,098
-45% -$112K ﹤0.01% 3070
2021
Q2 		$314K Buy
+24,500
New +$263K ﹤0.01% 2823

Other funds holding ZVRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

New York State Common Retirement Fund's ZVRA Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Zevra Therapeutics (ZVRA) stake by 95% in Q2 2026, buying an estimated $405K and bringing the position to 74,742 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #1723.

New York State Common Retirement Fund first reported a position in ZVRA in Q2 2021 and has held it in 18 quarters since. 157 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

  • New York State Common Retirement Fund held 74,742 shares of Zevra Therapeutics worth $1.07M as of Q2 2026.
  • New York State Common Retirement Fund bought 36,393 Zevra Therapeutics shares in Q2 2026, an estimated $405K.
  • Zevra Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1723 holding.
  • New York State Common Retirement Fund first reported a position in Zevra Therapeutics in Q2 2021 and has held it in 18 quarters since.
  • 157 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.